Call Options

19 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $240,000 - $365,900
2,000 New
2,000 $252,000
Q3 2023

Nov 15, 2023

BUY
$138.78 - $176.51 $69,390 - $88,255
500 Added 23.81%
2,600 $413,000
Q2 2023

Aug 23, 2023

BUY
$138.42 - $180.31 $290,682 - $378,651
2,100 New
2,100 $297,000
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $1.45 Million - $2.32 Million
-9,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $2.23 Million - $2.74 Million
9,000 New
9,000 $2.35 Million
Q3 2021

Nov 12, 2021

SELL
$194.77 - $324.21 $895,942 - $1.49 Million
-4,600 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$165.87 - $220.95 $763,002 - $1.02 Million
4,600 New
4,600 $939,000
Q1 2021

May 14, 2021

SELL
$180.37 - $226.26 $2.4 Million - $3.01 Million
-13,300 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$148.08 - $206.57 $1.53 Million - $2.13 Million
10,300 Added 343.33%
13,300 $2.52 Million
Q3 2020

Nov 13, 2020

BUY
$122.51 - $158.27 $367,530 - $474,810
3,000 New
3,000 $452,000
Q2 2020

Aug 13, 2020

SELL
$94.33 - $140.48 $245,258 - $365,248
-2,600 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$84.96 - $109.14 $832,607 - $1.07 Million
-9,800 Reduced 79.03%
2,600 $249,000
Q4 2019

Feb 12, 2020

SELL
$73.84 - $93.08 $1.85 Million - $2.34 Million
-25,100 Reduced 66.93%
12,400 $1.14 Million
Q3 2019

Nov 14, 2019

SELL
$76.65 - $95.51 $114,975 - $143,265
-1,500 Reduced 3.85%
37,500 $2.87 Million
Q2 2019

Aug 20, 2019

BUY
$54.2 - $85.95 $2.11 Million - $3.35 Million
39,000 New
39,000 $3.35 Million
Q4 2018

Feb 14, 2019

SELL
$48.26 - $68.88 $386,080 - $551,040
-8,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$46.8 - $58.97 $374,400 - $471,760
8,000 New
8,000 $444,000
Q4 2017

Feb 14, 2018

SELL
$32.53 - $38.92 $211,445 - $252,980
-6,500 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$36.98 - $46.06 $240,369 - $299,390
6,500
6,500 $249,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.